HEOR / Real-World Evidence (RWE) Shops
Illustrative scenario

Faster HTA Submissions, Fewer Formula Errors: Automating Budget Impact Model Scenarios

Missing an ICER or NICE submission deadline because your budget impact model scenario runs are stuck behind a two-to-three-week manual Excel update cycle is a market access problem with a concrete commercial cost. For a VP of Market Access Analytics managing an HTA submission pipeline across ICER, NICE, and G-BA, a single delayed submission can shift a formulary inclusion timeline by months — and payer reviewers finding formula errors during technical review costs far more in revision cycles than the original delay.

Up and running in ~6 wkFor: VP Market Access Analytics
Estimate your payback
~3 mo
Payback period
$2.1M
Est. savings / year
+$1.5M
Year-1 net

Rough estimate — change the numbers to match your business. We scope the real figures with you on a call.

Why Manual Excel BIM Workflows Break Under HTA Pressure

Budget impact models for HTA submissions are complex — multiple payer scenarios, sensitivity analyses, population-specific parameters, and cross-referenced formula structures that evolve through multiple draft cycles. When scenario runs require manual Excel updates, each iteration carries formula error risk, and the 2–3 week turnaround typically reflects both the update time and the QC review needed to catch errors before submission. ICER and NICE technical reviewers who find formula errors in the submitted model don't just ask for corrections — they question the analytical credibility of the entire submission.

Parameterized Scenario Execution with Built-In Integrity Validation

An AI Labor Company agent extracts your budget impact model scenario logic from historical BIM structures stored in Analytica and Excel archives, along with payer reviewer feedback from past submissions. The agent accepts structured scenario inputs — population parameters, market share assumptions, payer mix configurations — and executes the full scenario run, validating formula integrity across the model before generating output. Scenario results are packaged for VP Market Access Analytics review and version-controlled in Confluence for the HTA submission workflow. This typically compresses BIM scenario turnaround from 2–3 weeks to under five days while eliminating the post-submission formula errors that generate ICER and NICE technical review flags. The agent is live within approximately six weeks.

The Business Case: Protecting Market Access Timelines

HTA submission delays and post-submission technical reviews are revenue-timing problems. A delayed ICER assessment pushes US payer negotiation timelines; a NICE technical review request adds months to UK formulary inclusion. For a product generating $500M–$3B in revenue, those delays translate directly into launch timing impact. The more immediately measurable benefit is the elimination of revision cycles triggered by formula errors — which, beyond the analyst time cost, damage the evidentiary credibility of the submission itself. Reliable, validated scenario output is foundational to the market access argument.

Works with
AnalyticaExcelTableauConfluenceVeeva Vault RIM
Questions

Can the agent handle the different structural requirements of ICER, NICE, and G-BA budget impact models?

The agent learns format and structural requirements from your historical BIM archive by submission type. ICER, NICE, and G-BA models each have distinct conventions, and the agent applies the appropriate structure based on the target submission authority.

What kind of formula integrity validation does the agent perform?

The agent checks cross-referenced formulas for circular dependencies, confirms that parameter inputs propagate correctly through the model structure, and flags any output values that fall outside expected ranges given the input scenario. It does not validate the economic assumptions themselves — that judgment remains with the market access analytics team.

How does the agent handle scenario requests that require inputs not previously used in the BIM?

Novel parameter combinations are flagged for analyst review before the scenario run executes. This prevents the agent from producing output based on untested model territory without explicit analyst sign-off.

Related use cases

Illustrative scenario for healthcare, pharma & life sciences. Figures are example ranges, not guarantees — we scope real numbers with you on a call.

Want this running in your business?

We'll scope an agent for this on a free 15-minute call.

Book a free call